Abstract
In macromolecular crystallography, the rigorous detection of changed states (for example, ligand binding) is difficult unless signal is strong. Ambiguous (‘weak’ or ‘noisy’) density is experimentally common, since molecular states are generally only fractionally present in the crystal. Existing methodologies focus on generating maximally accurate maps whereby minor states become discernible; in practice, such map interpretation is disappointingly subjective, timeconsuming and methodologically unsound. Here we report the PanDDA method, which automatically reveals clear electron density for the changed state—even from inaccurate maps—by subtracting a proportion of the confounding ‘ground state’; changed states are objectively identified from statistical analysis of density distributions. The method is completely general, implying new best practice for all changedstate studies, including the routine collection of multiple groundstate crystals. More generally, these results demonstrate: the incompleteness of atomic models; that single data sets contain insufficient information to model them fully; and that accuracy requires further mapdeconvolution approaches.
Introduction
Besides its use for resolving the overall threedimensional (3D) structure of biomolecules, macromolecular Xray crystallography (MX) is deployed extensively to observe small changes to known structures, especially compound binding in liganddiscovery and development projects. Arriving at the final model once initial electron density estimates are available (after ‘phasing’), relies on a longestablished and rarely questioned paradigm: cycling between building atoms into the current density estimate and computationally optimizing the model against the measured data (‘refinement’). The latter improves the calculated phases and yields more detailed density that should reveal additional model omissions and errors; the process is assumed to converge on a model that fully describes the crystal’s content.
In practice, convergence is never convincingly achieved. Much density both strong and weak invariably remains unexplained (‘noisy’), hence the aphorism that ‘refinement […] is never finished, only abandoned’^{1}, and hence too the ‘Rfactor gap’^{2}, which has obdurately resisted all methodology advances. More recent work has shown that conventional singleconformation models are too simplistic to describe the crystal^{3,4,5}; and that electron density features far weaker than the conventional cutoff reflect model deficiencies rather than measurement error^{6,7}.
Evidently then, near convergence, conventionally calculated (sigmaAweighted^{8}) density derived from a single data set is necessary but insufficient to complete the model, as it shows a superposition of states that is currently impossible to deconvolute algorithmically. Nearly complete models with discrete yet uninterpretable superpositions are common in systematic studies of perturbations involving few atoms, such as ligand binding, photochemical changes or radiation damage. Since even strong biophysical effects are contingent on crystal packing or integrity, only a subset of the crystal may transition away from the ground state, even after extensive optimization of the experiment. Finally, all current modelling approaches ultimately rely on shape matching, and density superpositions are susceptible to interpretation errors and bias^{9,10,11} (such as the problem of the ‘Ligand of Desire’^{9}).
Existing methods to autogenerate multiconformer models^{4,5} are not relevant when changes are chemical, and moreover have had little takeup, presumably because neither is explicit modelling involved nor have robust validation criteria emerged to allay longcultivated fears of overfitting^{12}. Approaches from timeresolved crystallography^{13} apply only to specialized experiments.
In this work, we show that unencumbered views of the changed, nonground state can be obtained by recasting the problem as a multidata set, 3D backgroundcorrection problem (Fig. 1), which allows the relevant signal to be extracted from conventional singledata set density. An accurate estimate of the background can be obtained by averaging nearconvergence density, in real space and after local alignment, from dozens (>30) of independently measured but approximately identical groundstate crystals. Subtraction of a suitable fraction of this background estimate from the nearconvergence density of a data set containing a putative changed state, yields a residual partialdifference map that we call an event map, which is in general fully interpretable:
Identifying the optimal Background Density Correction factor (BDC) is essential for extracting the best signal, as illustrated schematically in Fig. 2, which also illustrates the problems with using conventional maps for the identification of minor crystallographic states.
Results
The PanDDA algorithm
Our new method—PanDataset Density Analysis (PanDDA)—comprises: the characterization of a set of related crystallographic data sets of the same crystal form; the identification of (binding) events; and the subtraction of ground state density to reveal clear density for events.
The method builds on the principle of isomorphous difference (F_{o}–F_{o}) maps^{14}, but analyses many maps simultaneously by first locally aligning maps in real space to bypass the requirement of strict isomorphism, and then directly comparing the best estimate of true electron density, namely sigmaAweighted (2mF_{o}–DF_{c}) maps from latestage refinement, which ensures that maps are correctly scaled.
Using multiple maps allows a Zscore measure to be calculated at each point in every data set, that reflects how significantly the data set deviates from the ensemble of data sets at that point in space. Zscores are assembled into spatial Zmaps, and clusters of large Zscores are an objective and statistically meaningful measure for potentially interesting crystallographic signal—events—such as a binding ligand. Using Zmaps addresses the common pitfall of overinterpreting density that is in fact ground state density, since in such cases, Zscores will be small. Equally importantly, Zmaps also make it possible to identify weak changed states (for example, lowoccupancy ligands) that do not yield strong difference (mF_{o}–DF_{c}) density.
Finally, the precise localization of each change enables reliable background subtraction at that site, where the optimal BDC is estimated as the value for which the ground statesubtracted map is locally least correlated to the groundstate map, relative to a normalizing global correlation across the unit cell (see Methods section). Using an averaged groundstate map for subtraction, as opposed to a single groundstate map, reduces experimental noise in the groundstate estimate and thereby also in the event map. Furthermore, averaging over multiple data sets minimizes the influence of stochastic variation between the data sets^{15} (characterized and discussed in Supplementary Methods). Finally, the averaging generates an estimate of the ground state that can be used directly as density, bypassing the need for any subjective modelling and map interpretation. The BDC is determined algorithmically and objectively, and results in event map density approximating only the changed configuration of the site, including protein backbone and sidechain conformations induced by the change.
Application to crystallographic fragment screening data
We demonstrate the power of the method by applying it to the most demanding type of changedstate study, namely crystallographic fragment screening^{16,17}, which attempts to observe in electron density the rare and often low occupancy binding events that occur when a relatively large (200–1,000) library of weakbinding ‘fragment’ compounds (150–300 Da, 100 μM–10 mM)^{18,19} are added individually or as cocktails to a series of equivalent crystals. Conventionally, the analysis is challenging as it involves inspecting a lot of 3D space—the whole unit cell in each data set—for convincing evidence of bound fragments (‘hits’). In contrast, PanDDA directly eliminates the thousands of strong electron density blobs with no statistical significance, objectively identifying only regions that are unique to each data set; the groundstate data sets are provided by the many hitfree crystals.
Applied to a series of fragment screens (Table 1), PanDDA yielded markedly more hits than manual inspection of density, far more quickly and all with high confidence (Figs 3 and 4; Supplementary Figs 1–6), in both known binding sites and new allosteric sites (Fig. 4d). Several fragments induced significant reordering of sections of the protein that could only be modelled with PanDDA event maps (Fig. 4a–c, Supplementary Fig. 1a–c), whilst also enabling the identification of mislabelled ligands and the discovery of experimental errors (Supplementary Figs 1d–f and 3d–f). Models erroneously built into misleading conventional density could be discarded with statistical confidence, and the binding of chemically elaborated hit compounds could be analysed more reliably. Full experimental details and complete descriptions are provided in Supplementary Note 1. The method also effectively disambiguates density in conventional ligandbinding studies with ligands cocrystallized and a suboptimal number of groundstate data sets (Supplementary Note 2).
Strikingly, detection of weak binding events is simple even when phases are far from convergence (Fig. 5).
Model validation
Model validation is a longestablished bedrock of crystallographic analysis^{12}, and crucially requires a model that is numerically stable in refinement. As ligands—but especially fragments—invariably bind at subunitary occupancy, we generate an atomic ensemble model that reflects the crystal content implied by the density correction: the changed state modelled from event maps is combined with the groundstate model, with initial occupancy of the changed state set to 2*(1BDC) (discussed in Supplementary Methods). Incorporation of the ground state into the model enforces our Bayesian prior knowledge of the crystal, that the ligand is most likely not bound to all copies of the protein in the crystal, and a superposition of the two states is thus the most likely situation. These ensemble models are indeed wellbehaved in refinement, provided the ground state can be easily represented by an atomic model.
After refinement, some ligands built into strong event density would be considered invalid by comparison of the model and the refined density (Supplementary Fig. 7), or the subjective but bestpractice criterion^{9} of visual assessment of agreement between model and conventional OMIT maps. As this is counterintuitive, given the clarity of the event maps, we instead formulated the following strong objective validation principles:

1
The changedstate partial model must conform to calculable numerical criteria (Table 2). We adopt established requirements: a strong correlation between the model and the observed density (realspace correlation coefficient, RSCC>0.7) and that ligand Bfactors must be comparable to those of surrounding residues. We also apply a new metric, that modelling and refinement should result in negligible difference density around the site (realspace Zdifference score, RSZD<3)^{20}, and further require that the model must not move under refinement (low heavyatom rootmeansquared deviation before versus after). These metrics are fully defined in Methods and shown for all models in Supplementary Tables 1–4.

2
The ground state partial model is considered an immutable component of the crystal, with a status similar to common restraints (for example, geometry or noncrystallographic symmetry), as in general there is not enough diffraction information to propose otherwise. Thus, the ground state model needs to be fully complete before incorporation into the ensemble, and during further cycles of model building, it may not be altered, as it is a strong Bayesian prior. To stabilize refinement, it may need to be strongly restrained to the original ground state model (by external restraints using, for example, PROSMART^{21}).

3
The primary event density must always be available when disseminating such models. All crystallographic data used for the PanDDA analysis must also be made available so that the analysis may be reproduced.
The group deposition feature recently added by the PDB^{22} makes it realistic to deposit all the many changed and groundstate structures, as well as event maps (see Data Availability). On the other hand, standard mechanisms for presenting the validation evidence described above are yet to be finalized. Refinement programs do not yet support some external restraints that we predict will be important for numerical stability at low resolution or for very low occupancy at high resolution, in particular restraining relative Bfactors to stabilize occupancy refinement; this is the subject of future work.
In general, only the changed state will be of primary scientific interest in the refined model, with the ground state essentially an experimental artefact. Unlike the artefacts inherent in any crystal structure, here they are explicitly declared and need not be inferred by further analysis. Structure repositories, whether public (PDB) or internal, would ideally support this by removing the ground state for normal use; this is only possible when states are logically labelled, as discussed in Methods.
Discussion
The PanDDA algorithm fundamentally revises current methods through a more correct treatment of the crystallographic data, not only yielding dramatically improved signaltonoise, but also providing rigorous measures of confidence in identified signal. This allows far more subtle changes to be modelled, whose importance will be experiment and contextdependent: in ligand development, evidence of weak binding is now known to be productive for optimizing binding potency^{23}. More generally, occupancy is subject to diffusion and other solidstate effects inherent to the crystalline state, and will be an imperfect proxy for the scientific import of a change of interest. What matters most is that any changed state can be viewed as objectively and modelled as accurately as possible, which is what the PanDDA approach allows.
We thus propose a new standard practice for ligand binding and other changedstate studies, namely the collection of a series of ground state data sets before proceeding with the putative changedstate data sets, to provide the contrast necessary to identify the changes of interest.
Retrospective analysis indicates that ∼30 data sets are required for full convergence of the statistical model (Supplementary Methods), an experiment that can be completed within hours at modern synchrotron beamlines with fast pixel detectors^{24} and sample automation^{25}, and that needs to be performed only once per crystal form. To address such an experiment's other bottleneck, the logistics of analysing large numbers of data sets, the PanDDA implementation includes graphical tools and various commandline options.
This number of data sets is required for identification of subtle changes from the ground state to be sensitive and robust, by ensuring that the Zmap represents a true statistical measure of changedstate signal. However, the background correction itself still works when fewer than 30 data sets are available (Supplementary Note 2), the tradeoff being potentially reduced quality of the event maps. Future work will address whether the number of required data sets can be identified a priori for a given crystal system.
The PanDDA method is applicable and effective at any resolution, though at lower resolutions, as maps become less precise, higher occupancies of changed states will in general be required for them to be detected by Zscore. What matters most is the consistency of groundstate data sets so that they can be represented well by an average; therefore, in regions of crystals that vary considerably, such as crystal contacts, statistical confidence is reduced similarly to low resolutions.
As the algorithm currently uses a contrastmaximization approach to estimate BDC, event map density for changes appears somewhat stronger than density for unchanged atoms (typically, surrounding protein). In practice, this is not problematic, as the density for the changed states is generally clear, and unchanged conformations do not require modelling anyway. Establishing a BDC procedure that evens out this difference will require accounting for phase bias in the event maps, but falls outside the scope of this work.
In principle, the PanDDA approach will allow comparisons between different crystal forms of the same protein. However, since functionally important conformational changes are not only common in such cases but by their nature affect the functionally interesting regions, algorithmic treatment of the local alignment is complex and the topic of future work.
Our results upend a longheld tenet in macromolecular crystallographic model building, that to visualize subtle features requires optimal phase estimates and thus a model as complete and globally errorfree as possible^{26}. Conscientiously observed, this places a heavy time burden on the analysing scientist as it demands multiple iterations of modelling for each data set. The PanDDA approach makes this both practically and theoretically unnecessary: a single local modelling step fully validates an interpretation, even when the model retains minor problems elsewhere.
More generally, we submit that a qualitative shift in approaches to generating crystallographic models is now due. PanDDA addresses one class of experiments, those involving induced local changes, but all problems of uninterpretable density, and indeed some of the Rfactor gap^{2}, should be addressable by analogous map deconvolution methods. Multidata set experiments are no longer difficult; nevertheless, existing tools for treating them focus on pursuing a single, representative data set through averaging^{27}. Instead, what now appears key is to establish methods for targeted perturbations of poorly ordered regions, along with rigorous algorithms for reconstructing and visualizing discrete states, and for subsequent model validation.
Methods
The PanDDA algorithm is schematically outlined in Supplementary Fig. 9 (Supplementary Methods).
Data set preparation
The input to PanDDA is a series of refined crystallographic data sets, each consisting of a refined structure and associated diffraction data, including 2mF_{o}–DF_{c} structure factors. These can come from any refinement program, as long as all data sets are refined using the same initial atomic model and the same protocol. All models of the protein must be identical, up to the numbering and labelling of atoms. All data sets used in this paper were prepared using the Dimple pipeline (part of CCP4 (ref. 28)), from reference models including solvent molecules; there is no requirement to remove solvent atoms from known binding sites.
Structure and map alignment
To allow map voxels to be compared between crystals that are not exactly isomorphous, maps are aligned using the refined models as reference points.
The input protein structures are aligned using a flexible alignment algorithm (Supplementary Methods). Sections of the protein are aligned separately, to give alignment matrices for that section. The alignments generated from the structures are stored and are used to transform and thereby align the electron density maps.
Handling variations of map resolutions
To allow map voxels to be compared between crystals, maps have to be calculated at the same level of detail, even though crystals can diffract to a wide range of resolutions. For analysing a specific data set, its full resolution is used; but for contributing to the analysis of a different data set, higher resolution data sets are truncated to the resolution of the target data set, while lower resolution data sets are ignored. Therefore, we analyse the collection of data sets at a number of resolutions, and high resolution data sets are used multiple times for characterization at lower resolutions, but will only be analysed once, at their highest possible resolution. Maps are recalculated using truncated diffraction data at each different resolution limit. Thus, if processing in resolution bins of 1.0, 1.5, 2, and 2.5 Å, a 1.2 Å data set would be analysed at 1.5 Å, but also be used to build distributions at 2 Å and 2.5 Å.
Fourier terms omitted in a given map, as happens when reflections are unobserved and then effectively set to zero, lead to systematic changes in electron density throughout the unit cell that strongly affect the outlier analysis; strong lowresolution terms are particularly problematic. Therefore, reflections in all data sets are truncated to the set of miller indices common to all data sets; and for map calculation, all missing Fourier terms are estimated as DF_{c}, which refinement programs perform automatically as long as the indices are correctly included in the reflection files.
Truncated 2mF_{o}–DF_{c} structure factors are Fouriertransformed to generate maps. These maps are aligned using the alignment transformations from the flexible alignment.
Statistical model
Once maps for a particular resolution have been aligned, a statistical model is parameterized using the electron density of the groundstate data sets. The aligned maps are placed on an isotropic Cartesian grid, and the electron density is sampled at each grid point of each data set. The model treats the observed value of the electron density in data set i, at grid point m, as being sampled from a distribution
where models the natural variation in the electron density at point m, independent of data set, and ɛ_{i} represents the experimental uncertainty in the electron density in data set i. The variability of the term accounts for the fact that the crystals are not identical, and that small local fluctuations may exist between the crystals. These areas are most likely to be in the crystal contacts, or flexible areas of the protein. represents the ‘true’ (unmeasurable) electron density for this crystal form, of which each crystal (and associated data set) is a sample.
The simplest model is to assume that both the uncertainty in electron density values as well as variation in electron density at a point arising from differences between the crystals, can be modelled by a normal distribution. Therefore, if
then
where μ_{m} is the mean value of the electron density at point m, s_{m} is the variance of the ‘true’ electron density at point m, and σ_{i} is the uncertainty in data set i. Under this model, the parameters μ_{m} are estimated by taking the unweighted average of all of the ground state densities.
The mean ground state map is used to estimate the data set uncertainty, σ_{i}, for all data sets as follows. Subtracting the mean map from each data set map we obtain a mean difference map. By assuming that the experimental and model uncertainty in the electron density map are the major contributors to deviations from the mean map, the histogram of the meandifference map values is used to estimate the total uncertainty of the data set. Calculating the quantiles of a theoretical normal distribution and plotting them against the quantiles from the meandifference map, yields a QQ plot where the slope of the central portion of the map (between the ±1.5 theoretical quantiles) gives an estimate of the uncertainty of the data set (Supplementary Fig. 11a). This is equivalent to the method used in Tickle (2012) for calculating the uncertainty of an electron density map^{20}.
To estimate s_{m}, a maximum likelihood method is applied on our model in (4), using the observed values , as well as estimates for σ_{i} and μ_{m} for the groundstate data sets (Supplementary Methods). An example comparison of the ‘raw’ standard deviations of the grid points (simple s.d. of electron density values, not accounting for observation error) and the ‘adjusted’ values is shown in Supplementary Fig. 12. This adjustment results in the majority of points having no variation that is not accounted for by the data set uncertainties; the remaining points have nonnegligible variation, with nonzero s_{m}, and these indicate naturally variable regions.
Calculation of Zmaps
The parameterized statistical model allows the identification of areas of individual data set maps that deviate significantly from the mean map: ‘events’. Zscores are calculated by
where large Zscores indicate significant deviations from the mean map. The distributions of Zscores for a particular data set have improved normality compared to the simple differences from the mean (Supplementary Fig. 11b), as expected.
Regions of individual data sets are identified as significant by contouring Zmaps at Z=2.5, and filtering remaining blobs by a minimum peak value of Z=3 and a minimum volume of 10 Å^{3} (volume of a water molecule is ∼30 Å^{3}). Neighbouring blobs are grouped together if the minimum distance between them is <5 Å. These parameters were identified on the BAZ2B data set, and found appropriate in subsequent studies and are therefore the current program defaults.
Calculation of event maps
For identified events, the background density correction (BDC) factor is estimated as follows. Different fractions of the mean map are subtracted from the data set map, and the correlation between the resulting map and the mean map is calculated both globally and for the area around the event, defined by the blob identified in the Zmap expanded by 1 Å.
Globally, the data set map looks similar to the mean map, so plotting the global correlation against the subtracted fraction yields a signaltonoise curve, dropping off at a speed related to the noise in the data set (green dashed line, Supplementary Fig. 15). Locally to the identified site, however, the data set map is a superposition between something similar to the mean map and something that is unrelated (for example, density of bound ligand). As more of the mean map is subtracted, the local correlation between the mean map and the resulting map (black dashed line, Supplementary Fig. 15) will decrease faster than the global correlation. Subtracting the local correlation curve from the global correlation curve, BDC is estimated where the difference between these two correlation curves is maximized (blue solid line, Supplementary Fig. 15). The final event map is calculated as in equation (1).
Model building and refinement
Interesting sites are identified by Zmaps and modelling is performed using a combination of Zmaps and event maps, similarly to the way that mF_{o}–DF_{c} maps may be used to guide the modelling of 2mF_{o}–DF_{c} maps. Modelling takes place in the aligned reference frame, as defined in Supplementary Methods.
After modelling of the changed state, the new conformations of the protein are merged with the ground state model. Atoms in the ground state that are not present or have moved in the changed state are assigned to a previously unused conformer (for example, C). Similarly, atoms in the changed state model that are not present in the ground state, or have moved, are assigned another unused conformer (for example, D). Atoms that are not changed between the two states remain unaltered. The resulting ensemble models are then backtransformed, using the flexible alignments, to the original crystallographic frame for refinement.
The models in Table 1 have then been refined as an ensemble using phenix.refine^{29,30}, under conventional resolutiondependant refinement protocols, with constrained occupancy groups corresponding to the bound and unbound structures to ensure that the occupancies of the bound and unbound states sum to unity.
Because of the methodical way in which the ensembles are generated, the changed state model can be extracted simply by removing the atoms corresponding to the changed ground state atoms (that is, conformer C in the above example).
Validation
The atomic model of the changed state is validated by four quality metrics (Table 2). Two are electron density scores, generated by EDSTATS^{20}: realspace correlation coefficient (RSCC) reflects the fit of the atoms to the experimental density, and should typically be greater than 0.7; while realspace Zdifference score (RSZD) measures the amount of difference density that is found around these atoms, and should be below 3. The Bfactor ratio measures the consistency of the model with surrounding protein, and is calculated from the Bfactors of the changed atoms and all sidechain atoms within 4 Å, respectively. Large values (>3) reflect poor evidence for the model, and intermediate values (1.5+) indicate errors in refinement or modelling; for weaklybinding ligands, systematically large ratios may be justifiable. Coordinate rootmeansquared deviation (RMSD) compares the positions of all atoms built into event density, with their positions after final refinement, and should be below 1 Å.
Implementation
PanDDA is implemented in Python and relies heavily on the CCTBX^{31}. It has been tested extensively for robustness and usability by users of Diamond’s XChem fragment screening facility. Source code is available on bitbucket (https://bitbucket.org/pandda/pandda) or as part of CCP4 (ref. 28). A manual and tutorial are available at https://pandda.bitbucket.io. Processing 200–500 data sets on a 3.7 GHz QuadCore Intel Xeon with 32 GB of RAM takes ∼3–10+ hours depending on resolution binning and size of crystallographic unit cell.
Data availability
Models were built and refined for those ligands that could be uniquely identified in the event maps, except for those that interact extensively with the crystal contacts and are therefore unlikely to be biologically relevant. Modelled data sets (those in Table 1) and unmodelled data sets have been deposited in the PDB using the new group deposition system (PDB codes for each data set are stated in Supplementary Table 5); structure factors for event maps are included within each mmCIF file downloadable from the PDB. PDB group deposition IDs for the ligandbound structures are G_1002018 (BAZ2B), G_1002020 (JMJD2D), G_1002022 (BRD1), and G_1002024 (SP100); group IDs for the automatically refined structures are G_1002019 (BAZ2B), G_1002021 (JMJD2D), G_1002023 (BRD1), and G_1002025 (SP100). However, since navigation of this large numbers of structures and event maps remains an obstacle to interpretation, interactive summary pages^{32,33,34,35} for each fragment screen have been uploaded to Zenodo (https://zenodo.org); zip files of all of the crystallographic data have also been uploaded^{36,37,38,39} (Supplementary Table 5). All other data are available from the corresponding author upon reasonable request.
Additional information
How to cite this article: Pearce, N. M. et al. A multicrystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density. Nat. Commun. 8, 15123 doi: 10.1038/ncomms15123 (2017).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
 1
Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. Sect. A Found. Crystallogr. 64, 112–122 (2007).
 2
Holton, J. M., Classen, S., Frankel, K. A. & Tainer, J. A. The Rfactor gap in macromolecular crystallography: an untapped potential for insights on accurate structures. FEBS J. 281, 4046–4060 (2014).
 3
Burnley, B. T., Afonine, P. V., Adams, P. D. & Gros, P. Modelling dynamics in protein crystal structures by ensemble refinement. Elife 1, e00311 (2012).
 4
DePristo, M. A., De Bakker, P. I. W., Johnson, R. J. K. & Blundell, T. L. Crystallographic refinement by knowledgebased exploration of complex energy landscapes. Structure 13, 1311–1319 (2005).
 5
Van Den Bedem, H., Dhanik, A., Latombe, J. C. & Deacon, A. M. Modeling discrete heterogeneity in Xray diffraction data by fitting multiconformers. Acta Crystallogr. Sect. D Biol. Crystallogr. 65, 1107–1117 (2009).
 6
Lang, P. T. et al. Automated electrondensity sampling reveals widespread conformational polymorphism in proteins. Protein Sci. 19, 1420–1431 (2010).
 7
Lang, P. T., Holton, J. M., Fraser, J. S. & Alber, T. Protein structural ensembles are revealed by redefining Xray electron density noise. Proc. Natl Acad. Sci. USA 111, 237–242 (2014).
 8
Read, R. J. Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallogr. Sect. A Found. Crystallogr. 42, 140–149 (1986).
 9
Pozharski, E., Weichenberger, C. X. & Rupp, B. Techniques, tools and best practices for ligand electrondensity analysis and results from their application to deposited crystal structures. Acta Crystallogr. Sect. D Biol. Crystallogr. 69, 150–167 (2013).
 10
Stanfield, R., Pozharski, E. & Rupp, B. Comment on Three Xray Crystal Structure Papers. J. Immunol. 196, 521–524 (2016).
 11
Rupp, B. & Segelke, B. Questions about the structure of the botulinum neurotoxin B light chain in complex with a target peptide. Nat. Struct. Biol 8, 663–664 (2001).
 12
Kleywegt, G. J. & Jones, T. A. Where freedom is given, liberties are taken. Structure 3, 535–540 (1995).
 13
Yorke, B. A., Beddard, G. S., Owen, R. L. & Pearson, A. R. Timeresolved crystallography using the Hadamard transform. Nat. Methods 11, 1131–1134 (2014).
 14
Rould, M. A. & Carter, C. W. Isomorphous Difference Methods. Methods Enzymol. 374, 145–163 (2003).
 15
Keedy, D. A. et al. Crystal cryocooling distorts conformational heterogeneity in a model michaelis complex of DHFR. Structure 22, 899–910 (2014).
 16
Patel, D., Bauman, J. D. & Arnold, E. Advantages of crystallographic fragment screening: Functional and mechanistic insights from a powerful platform for efficient drug discovery. Prog. Biophys. Mol. Biol. 116, 92–100 (2014).
 17
Cox, O. B. et al. A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain. Chem. Sci. 7, 2322–2330 (2016).
 18
Murray, C. W. & Verdonk, M. L. The consequences of translational and rotational entropy lost by small molecules on binding to proteins. J. Comput. Aided. Mol. Des. 16, 741–753 (2002).
 19
Mooij, W. T. M. et al. Automated proteinligand crystallography for structurebased drug design. Chem. Med. Chem. 1, 827–838 (2006).
 20
Tickle, I. J. Statistical quality indicators for electrondensity maps. Acta Crystallogr. Sect. D Biol. Crystallogr. 68, 454–467 (2012).
 21
Nicholls, R. A., Long, F. & Murshudov, G. N. Lowresolution refinement tools in REFMAC5. Acta Crystallogr. Sect. D Biol. Crystallogr. 68, 404–417 (2012).
 22
Berman, H. M. et al. The Protein Data Bank. Nucleic Acids Res. 28, 235–242 (2000).
 23
Schiebel, J. et al. Six Biophysical Screening Methods Miss a Large Proportion of Crystallographically Discovered Fragment Hits: A Case Study. ACS Chem. Biol. 11, 1693–1701 (2016).
 24
Mueller, M., Wang, M. & SchulzeBriese, C. Optimal fine phislicing for singlephotoncounting pixel detectors. Acta Crystallogr. Sect. D Biol. Crystallogr. 68, 42–56 (2012).
 25
Helliwell, J. R. & Mitchell, E. P. Synchrotron radiation macromolecular crystallography: Science and spinoffs. IUCrJ 2, 283–291 (2015).
 26
Schiebel, J. et al. Highthroughput crystallography: reliable and efficient identification of fragment hits. Structure 24, 1398–1409 (2016).
 27
Foadi, J. et al. Clustering procedures for the optimal selection of data sets from multiple crystals in macromolecular crystallography. Acta Crystallogr. Sect. D Biol. Crystallogr. 69, 1617–1632 (2013).
 28
Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. Sect. D Biol. Crystallogr. 67, 235–242 (2011).
 29
Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. Sect. D Biol. Crystallogr. 68, 352–367 (2012).
 30
Adams, P. D. et al. PHENIX: a comprehensive Pythonbased system for macromolecular structure solution. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 213–221 (2010).
 31
GrosseKunstleve, R. W., Sauter, N. K., Moriarty, N. W. & Adams, P. D. The Computational Crystallography Toolbox: crystallographic algorithms in a reusable software framework. J. Appl. Crystallogr. 35, 126–136 (2002).
 32
Krojer, T., Pearce, N. M., Bradley, A., Marsden, B. D. & von Delft, F. PanDDA analysis of BAZ2B screened against Zenobia Fragment Library (HTML Summary). Zenodo. Available at: https://zenodo.org/record/290199 (2017).
 33
Krojer, T., Pearce, N. M., Bradley, A., Marsden, B. D. & von Delft, F. PanDDA analysis of JMJD2D screened against Zenobia Fragment Library (HTML Summary). Zenodo. Available at: https://zenodo.org/record/290220 (2017).
 34
Krojer, T., Pearce, N. M., Collins, P., Talon, R. & von Delft, F. PanDDA analysis of BRD1 screened against 3DFragmentConsortium Fragment Library. (HTML Summary) Zenodo. Available at: https://zenodo.org/record/290217 (2017).
 35
Krojer, T., Pearce, N. M., Collins, P., Talon, R. & von Delft, F. PanDDA analysis of SP100 screened against selection of Maybridge Fragment Library (HTML Summary). Zenodo. Available at: https://zenodo.org/record/290201 (2017).
 36
Pearce, N. M., Bradley, A. R., Marsden, B. D. & von Delft, F. PanDDA analysis of BAZ2B screened against Zenobia Fragment Library [Dataset]. Zenodo. Available at: https://zenodo.org/record/48768 (2016).
 37
Pearce, N. M., Bradley, A. R., Marsden, B. D. & von Delft, F. PanDDA analysis of JMJD2D screened against Zenobia Fragment Library [Dataset]. Zenodo. Available at: https://zenodo.org/record/48770 (2016).
 38
Pearce, N. M., Krojer, T., Collins, P., Talon, R. & von Delft, F. PanDDA analysis of BRD1 screened against 3DFragment Consortium Fragment Library [Dataset]. Zenodo. Available at: https://zenodo.org/record/48769 (2016).
 39
Pearce, N. M., Krojer, T., Collins, P., Talon, R. & von Delft, F. PanDDA analysis of SP100 screened against selection of Maybridge Fragment Library [Dataset]. Zenodo. Available at: https://zenodo.org/record/48771 (2016).
Acknowledgements
We thank Randy Read and Garib Murshudov for many productive conversations, and Luis Ospina for discussions regarding the statistical model. All datasets were collected at Diamond Light Source beamline I03, and at Diamond Light Source beamline I041 as part of the SGCDiamond I041 XChem partnership. NMP and CMD recognize funding from EPSRC grant EP/G037280/1, UCB Pharma and Diamond Light Source. The SGC is a registered charity (No. 1097737) that receives funds from AbbVie, Bayer, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda and the Wellcome Trust (092809/Z/10/Z).
Author information
Affiliations
Contributions
N.M.P., C.M.D. and F. v.D. designed and conducted the research. N.M.P. developed and implemented the algorithm. A.R.B., P.C., T.K., R.P.N. and R.T. performed the experiments that yielded the crystallographic data. N.M.P. analysed the processed data. N.M.P., T.K. and R.T. established model validation criteria. T.K. enabled the deposition of the structures in the PDB and generated the HTML summary pages. B.D.M., S.K. and J.S. were involved in discussions of the project and revising the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary figures, supplementary tables, supplementary notes and supplementary methods. (PDF 9813 kb)
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Pearce, N., Krojer, T., Bradley, A. et al. A multicrystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density. Nat Commun 8, 15123 (2017). https://doi.org/10.1038/ncomms15123
Received:
Accepted:
Published:
Further reading

Detecting anomalies in Xray diffraction images using convolutional neural networks
Expert Systems with Applications (2021)

qFit 3: Protein and ligand multiconformer modeling for X‐ray crystallographic and single‐particle cryo‐EM density maps
Protein Science (2021)

Fragment and structurebased drug discovery for developing therapeutic agents targeting the DNA Damage Response
Progress in Biophysics and Molecular Biology (2021)

Fragment Screening Reveals Starting Points for Rational Design of Galactokinase 1 Inhibitors to Treat Classic Galactosemia
ACS Chemical Biology (2021)

Enhanced validation of smallmolecule ligands and carbohydrates in the Protein Data Bank
Structure (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.